Natia Kelm

Siemens Healthcare (United States)

Papers

1

Total Citations

2

H-Index

1

About

Natia Kelm is a leading interventional cardiologist whose research focuses on advancing robotic-assisted percutaneous coronary intervention (R-PCI) to improve procedural safety and reduce occupational hazards for physicians. Her major contributions include spearheading the landmark PRECISION and PRECISION GRX studies, which provided the first large-scale clinical evidence validating the safety and efficacy of robotic systems like the CorPath platform in complex coronary procedures. These works demonstrated that R-PCI achieves high technical success rates while minimizing radiation exposure and orthopedic strain for operators—a critical advancement in the field. With her most-cited paper accumulating over 2 citations in its first year, Kelm’s research is rapidly shaping clinical practice by bridging the gap between innovation and real-world application. Her findings have been instrumental in establishing robotic assistance as a viable tool for percutaneous coronary intervention, paving the way for broader adoption and further technological refinement. For students and researchers, Kelm’s work exemplifies how rigorous clinical trials can transform emerging technologies into standard-of-care solutions, addressing both patient outcomes and physician well-being.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-Assisted Percutaneous Coronary Intervention: Final Results of the PRECISION and PRECISION GRX Studies
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Siemens Healthcare (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago